搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
2 天
on MSN
FDA approves AstraZeneca's Imfinzi for limited-stage small cell lung cancer
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
FiercePharma
2 天
AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell ...
AstraZeneca has picked off another label expansion for its cancer blockbuster Imfinzi (durvalumab) as the FDA has ...
FierceBiotech
1 天
AstraZeneca, Daiichi share data behind Dato-DXd do-over amid 2nd bid for lung cancer approval
AstraZeneca and Daiichi Sankyo have shared the data they believe can secure approval for datopotamab deruxtecan (Dato-DXd) at ...
2 天
AstraZeneca’s Imfinzi approved in U.S. as immunotherapy regimen for LS-SCLC
Imfinzi has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer, LS-SCLC ...
STAT
5 天
Despite probe, China reimbursing AstraZeneca drug
The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite ...
2 天
FDA approves AstraZeneca’s Imfinzi to treat LS-SCLC
The US Food and Drug Administration (FDA) has approved AstraZeneca's human monoclonal antibody, Imfinzi (durvalumab), to ...
Benzinga.com
2 天
FDA Approves AstraZeneca's Blockbuster Cancer Drug Imfinzi For Aggressive Form Of Lung Cancer
FDA approves AstraZeneca’s Imfinzi for limited-stage small cell lung cancer, cutting the risk of death by 27% in the ADRIATIC ...
2 天
AstraZeneca announces FDA approval for Imfinzi
Imfinzi has been approved in the U.S. for the treatment of adult patients with limited-stage small cell lung cancer, or ...
BioSpace
5 天
AstraZeneca/Daiichi Sankyo, BioNTech, Merus to Present Promising Cancer Therapies at ESMO ...
At the conference, AstraZeneca and Daiichi Sankyo will present their case for Dato-DXd in NSCLC, while BioNTech and Merus ...
来自MSN
2 天
AstraZeneca's Imfinzi Gets FDA Nod for Expanded Use in SCLC
AstraZeneca AZN announced that the FDA has approved its blockbuster cancer drug Imfinzi (durvalumab) for treating ...
2 天
AstraZeneca cancer drug secures US approval
AstraZeneca drug Imfinzi has been approved for use in the US for patients with limited stage small cell lung cancer, the ...
Daily
1 天
AstraZeneca Imfinzi gets USFDA nod for limited-stage small cell lung cancer
AstraZeneca's Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈